ZheJiangTailin Bioengineering Co Ltd
SZSE:300813
ZheJiangTailin Bioengineering Co Ltd
SZSE:300813
Price:
28.13
CNY
1.11%
Market Closed
Market Cap:
¥3.4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
ZheJiangTailin Bioengineering Co Ltd
SZSE:300813
|
CN |
Income Statement
Earnings Waterfall
ZheJiangTailin Bioengineering Co Ltd
ZheJiangTailin Bioengineering Co Ltd
Income Statement
ZheJiangTailin Bioengineering Co Ltd
ZheJiangTailin Bioengineering Co Ltd
Currency: CNY
| Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
15
|
0
|
0
|
0
|
0
|
|
| Revenue |
173
N/A
|
172
-1%
|
181
+5%
|
182
+1%
|
185
+1%
|
192
+4%
|
200
+4%
|
208
+4%
|
225
+8%
|
249
+11%
|
283
+14%
|
307
+8%
|
318
+4%
|
335
+5%
|
374
+12%
|
381
+2%
|
371
-3%
|
343
-7%
|
270
-21%
|
271
+0%
|
284
+5%
|
309
+9%
|
349
+13%
|
336
-4%
|
339
+1%
|
320
-6%
|
340
+6%
|
|
| Gross Profit | ||||||||||||||||||||||||||||
| Cost of Revenue |
(73)
|
(71)
|
(77)
|
(78)
|
(74)
|
(77)
|
(75)
|
(81)
|
(88)
|
(98)
|
(109)
|
(124)
|
(133)
|
(146)
|
(178)
|
(188)
|
(183)
|
(171)
|
(136)
|
(146)
|
(157)
|
(173)
|
(198)
|
(192)
|
(191)
|
(177)
|
(189)
|
|
| Gross Profit |
100
N/A
|
101
+1%
|
104
+3%
|
104
+0%
|
110
+6%
|
115
+4%
|
126
+9%
|
127
+1%
|
138
+9%
|
150
+9%
|
174
+16%
|
182
+5%
|
185
+2%
|
188
+2%
|
196
+4%
|
194
-1%
|
188
-3%
|
172
-8%
|
134
-22%
|
125
-7%
|
126
+1%
|
136
+8%
|
151
+11%
|
144
-5%
|
147
+2%
|
143
-3%
|
151
+5%
|
|
| Operating Income | ||||||||||||||||||||||||||||
| Operating Expenses |
(47)
|
(49)
|
(66)
|
(64)
|
(76)
|
(76)
|
(79)
|
(80)
|
(83)
|
(95)
|
(114)
|
(119)
|
(120)
|
(125)
|
(126)
|
(120)
|
(127)
|
(129)
|
(123)
|
(122)
|
(125)
|
(124)
|
(136)
|
(133)
|
(132)
|
(135)
|
(142)
|
|
| Selling, General & Administrative |
(39)
|
(41)
|
(42)
|
(45)
|
(49)
|
(52)
|
(53)
|
(54)
|
(54)
|
(55)
|
(67)
|
(67)
|
(69)
|
(74)
|
(75)
|
(76)
|
(79)
|
(83)
|
(79)
|
(79)
|
(81)
|
(76)
|
(81)
|
(80)
|
(79)
|
(81)
|
(88)
|
|
| Research & Development |
(24)
|
(23)
|
(28)
|
(33)
|
(37)
|
(38)
|
(35)
|
(38)
|
(41)
|
(48)
|
(53)
|
(59)
|
(62)
|
(64)
|
(62)
|
(65)
|
(66)
|
(68)
|
(56)
|
(59)
|
(59)
|
(60)
|
(59)
|
(62)
|
(62)
|
(62)
|
(53)
|
|
| Depreciation & Amortization |
0
|
0
|
(6)
|
0
|
0
|
0
|
(6)
|
0
|
0
|
0
|
(5)
|
0
|
0
|
0
|
(6)
|
0
|
0
|
0
|
(6)
|
0
|
0
|
0
|
(7)
|
0
|
0
|
0
|
(9)
|
|
| Other Operating Expenses |
16
|
15
|
10
|
14
|
10
|
14
|
16
|
13
|
12
|
8
|
11
|
8
|
11
|
13
|
17
|
20
|
19
|
21
|
17
|
16
|
15
|
11
|
12
|
9
|
10
|
9
|
8
|
|
| Operating Income |
53
N/A
|
51
-3%
|
38
-26%
|
40
+4%
|
34
-14%
|
39
+14%
|
47
+20%
|
47
+1%
|
55
+17%
|
55
+1%
|
61
+10%
|
64
+5%
|
65
+2%
|
63
-2%
|
70
+11%
|
73
+4%
|
61
-17%
|
43
-30%
|
11
-74%
|
2
-78%
|
1
-69%
|
12
+1 500%
|
15
+27%
|
11
-30%
|
16
+46%
|
8
-46%
|
8
0%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||
| Interest Income Expense |
0
|
0
|
0
|
1
|
3
|
4
|
7
|
7
|
10
|
9
|
9
|
10
|
8
|
9
|
9
|
9
|
10
|
10
|
11
|
7
|
4
|
(0)
|
(3)
|
(0)
|
3
|
7
|
9
|
|
| Non-Reccuring Items |
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(0)
|
(0)
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(0)
|
|
| Total Other Income |
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
1
|
0
|
0
|
0
|
(1)
|
(0)
|
1
|
(0)
|
0
|
0
|
0
|
|
| Pre-Tax Income |
54
N/A
|
52
-3%
|
39
-26%
|
41
+6%
|
37
-9%
|
43
+16%
|
52
+20%
|
54
+5%
|
64
+18%
|
65
+1%
|
70
+8%
|
74
+6%
|
72
-2%
|
72
+0%
|
80
+10%
|
83
+4%
|
71
-14%
|
53
-25%
|
22
-59%
|
10
-56%
|
4
-55%
|
12
+165%
|
13
+9%
|
10
-19%
|
19
+80%
|
15
-18%
|
17
+10%
|
|
| Net Income | ||||||||||||||||||||||||||||
| Tax Provision |
(7)
|
(6)
|
(4)
|
(4)
|
(1)
|
(1)
|
(3)
|
(4)
|
(6)
|
(7)
|
(6)
|
(6)
|
(5)
|
(4)
|
(0)
|
0
|
0
|
(0)
|
(4)
|
(3)
|
(3)
|
(3)
|
(1)
|
(0)
|
1
|
1
|
(0)
|
|
| Income from Continuing Operations |
47
|
45
|
34
|
37
|
36
|
42
|
48
|
51
|
58
|
58
|
64
|
68
|
67
|
68
|
80
|
83
|
71
|
53
|
18
|
6
|
1
|
8
|
12
|
10
|
20
|
16
|
16
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
2
|
1
|
1
|
1
|
0
|
0
|
0
|
|
| Net Income (Common) |
47
N/A
|
45
-2%
|
34
-24%
|
37
+7%
|
36
-1%
|
42
+15%
|
48
+16%
|
51
+5%
|
58
+14%
|
58
+1%
|
64
+9%
|
68
+7%
|
67
-1%
|
68
+2%
|
80
+16%
|
83
+5%
|
72
-14%
|
54
-25%
|
20
-63%
|
8
-59%
|
3
-62%
|
10
+216%
|
13
+35%
|
11
-18%
|
20
+87%
|
16
-18%
|
16
+0%
|
|
| EPS (Diluted) |
1.19
N/A
|
1.16
-3%
|
0.55
-53%
|
0.74
+35%
|
0.72
-3%
|
0.8
+11%
|
0.46
-43%
|
0.6
+30%
|
0.69
+15%
|
0.69
N/A
|
0.59
-14%
|
0.82
+39%
|
0.81
-1%
|
0.57
-30%
|
0.71
+25%
|
0.79
+11%
|
0.65
-18%
|
0.52
-20%
|
0.17
-67%
|
0.07
-59%
|
0.03
-57%
|
0.09
+200%
|
0.12
+33%
|
0.1
-17%
|
0.17
+70%
|
0.14
-18%
|
0.14
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
